Rheumatoid arthritis

被引:33
|
作者
Diaz-Gonzalez, Federico [1 ,2 ,3 ]
Hernandez-Hernandeza, Maria V. [1 ]
机构
[1] Hosp Univ Canarias, Serv Reumatol, Tenerife, Spain
[2] Univ La Laguna, Dept Med Interna Dermatol & Psiquiatria, San Cristobal De La Lagun, Tenerife, Spain
[3] Univ La Laguna, Inst Univ Tecnol Biomed ITB, San Cristobal De La Lagun, Tenerife, Spain
来源
MEDICINA CLINICA | 2023年 / 161卷 / 12期
关键词
Rheumatoid arthritis; Etiopathogenesis; Treatment; Treat to target strategy; Disease activity; CITRULLINATED PEPTIDE ANTIBODIES; DISEASE-ACTIVITY SCORE; C-REACTIVE PROTEIN; CLASSIFICATION CRITERIA; CLINICAL-PRACTICE; AMERICAN-COLLEGE; DOUBLE-BLIND; ANTI-TNF; METHOTREXATE; MORTALITY;
D O I
10.1016/j.medcli.2023.07.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rheumatoid arthritis (RA) is a chronic inflammatory multisystemic disease of unknown etiology and autoimmune nature that predominantly affects peripheral joints in a symmetrical fashion. Although much progress has been made in understanding the pathophysiology of RA, its etiology remains unknown. Tumor necrosis factor (TNF)-a and interleukin (IL)-6 play the important roles in the pathogenesis and maintenance of inflammation in RA. The presence of anti-citrullinated peptide antibodies aids in the diagnosis in patients with undifferentiated polyarthritis and is associated with a more aggressive RA. The natural history of RA causes joint deformity and disability, as well as reduced life expectancy, both due to increased cardiovascular risk, pulmonary involvement, infections, iatrogenesis or tumors. Early diagnosis and the use of targeted drugs to induce early remission have improved the RA prognosis. (c) 2023 Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:533 / 542
页数:10
相关论文
共 50 条
  • [1] Treatment Strategies in Early Rheumatoid Arthritis and Prevention of Rheumatoid Arthritis
    Demoruelle, M. Kristen
    Deane, Kevin D.
    CURRENT RHEUMATOLOGY REPORTS, 2012, 14 (05) : 472 - 480
  • [2] Advances in the management of rheumatoid arthritis
    Dale, James
    SCOTTISH MEDICAL JOURNAL, 2015, 60 (03) : 108 - 114
  • [3] Diagnosis and classification of rheumatoid arthritis
    Kourilovitch, Maria
    Galarza-Maldonado, Claudio
    Ortiz-Prado, Esteban
    JOURNAL OF AUTOIMMUNITY, 2014, 48-49 : 26 - 30
  • [4] Rheumatoid Arthritis Activity and Treatment
    Urbina Aucancela, Cynthia Yesenia
    Carrera Montero, Geyla Yomar
    Quintana Dominguez, Omar Santiago
    Guama Bonilla, Lucia Nataly
    REVISTA CUBANA DE REUMATOLOGIA, 2020, 22 (03):
  • [5] Rheumatoid arthritis
    Wahle, M.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2009, 134 (36) : 1745 - 1754
  • [6] Remission in rheumatoid arthritis: is it all the same?
    Gul, Hanna L.
    Ferreira, Joana F.
    Emery, Paul
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2015, 8 (05) : 575 - 586
  • [7] Structural damages disturb functional improvement in patients with rheumatoid arthritis treated with etanercept
    Tanaka, Yoshiya
    Yamanaka, Hisashi
    Saito, Kazuyoshi
    Iwata, Shigeru
    Miyagawa, Ippei
    Seto, Yohei
    Momohara, Shigeki
    Nagasawa, Hayato
    Kameda, Hideto
    Kaneko, Yuko
    Izumi, Keisuke
    Amano, Koichi
    Takeuchi, Tsutomu
    MODERN RHEUMATOLOGY, 2012, 22 (02) : 186 - 194
  • [8] Heart Failure in Rheumatoid Arthritis: Clinical Implications
    Zambrano Zambrano, Alexis
    Del Rio Zanatta, Hector
    Gonzalez Espinoza, Andrea
    Bernal Alferes, Brian
    Zambrano Zambrano, Kevin
    Martinez Salazar, Julio
    Ixcamparij Rosales, Carlos Haroldo
    CURRENT HEART FAILURE REPORTS, 2024, 21 (06) : 530 - 540
  • [9] Ultrasonography in rheumatoid arthritis
    Sakellariou, G.
    Montecucco, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (01) : S20 - S25
  • [10] Biomarkers in Rheumatoid Arthritis
    Shapiro, Samantha C.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (05)